tradingkey.logo

QuidelOrtho Corp

QDEL
View Detailed Chart
29.100USD
+0.410+1.43%
Close 02/06, 16:00ETQuotes delayed by 15 min
1.98BMarket Cap
LossP/E TTM

QuidelOrtho Corp

29.100
+0.410+1.43%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.43%

5 Days

+7.10%

1 Month

-10.46%

6 Months

+24.15%

Year to Date

+1.89%

1 Year

-30.88%

View Detailed Chart

TradingKey Stock Score of QuidelOrtho Corp

Currency: USD Updated: 2026-02-06

Key Insights

QuidelOrtho Corp's fundamentals are relatively weak, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 72 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 37.43.In the medium term, the stock price is expected to trend up.Despite a weak stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

QuidelOrtho Corp's Score

Industry at a Glance

Industry Ranking
72 / 205
Overall Ranking
200 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

QuidelOrtho Corp Highlights

StrengthsRisks
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.
Fairly Valued
The company’s latest PE is -1.67, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 83.91M shares, decreasing 19.54% quarter-over-quarter.
Held by Invesco
Star Investor Invesco holds 245.91K shares of this stock.

Analyst Rating

Based on 8 analysts
Hold
Current Rating
37.429
Target Price
+30.46%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

QuidelOrtho Corp News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

QuidelOrtho Corp Info

QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.
Ticker SymbolQDEL
CompanyQuidelOrtho Corp
CEOBlaser (Brian J)
Websitehttps://www.quidelortho.com/
KeyAI